More Web Proxy on the site http://driver.im/

trimipramine (Q423498)

From Wikidata

Revision as of 11:41, 21 October 2024 by MatSuBot (talk | contribs) (‎Changed label, description and/or aliases in es: import labels from sitelinks)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

group of stereoisomers

trimeprimine
5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine
beta-methylimipramine
5-(gamma-dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
trimeproprimine
10,11-dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propanamine

Language	Label	Description	Also known as
default for all languages	No label defined		C20H26N2 RP-7162 7162 RP IL-6001
English	trimipramine	group of stereoisomers	trimeprimine 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine beta-methylimipramine 5-(gamma-dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine trimeproprimine 10,11-dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propanamine

Statements

group of stereoisomers

0 references

chemical compound

0 references

0 references

chemical structure

Trimipramin.svg
250 × 261; 17 KB

0 references

294.209599 dalton

1 reference

language of work or name

trimipramine (English)

3 October 2016

chemical formula

C₂₀H₂₆N₂

1 reference

language of work or name

trimipramine (English)

3 October 2016

canonical SMILES

CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C

1 reference

language of work or name

trimipramine (English)

3 October 2016

World Health Organisation international non-proprietary name

trimipramine (English)

1 reference

language of work or name

Trimipramine (English)

19 January 2016

medical condition treated

neurotic disorder

1 reference

language of work or name

13 December 2016

significant drug interaction

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

tranylcypromine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

mental status change

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

orthostatic hypotension

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

central respiratory depression

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

1 reference

sourcing circumstances

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

solute carrier family 6 member 3

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

Solute carrier family 6 member 2

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

solute carrier family 6 member 4

subject has role

enzyme inhibitor

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

17 August 2016

pregnancy category

Australian pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

selective serotonin reuptake inhibitor

1 reference

5 March 2018

adrenergic uptake inhibitors

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

15 March 2018

tricyclic antidepressant

1 reference

Medical Subject Headings

MeSH descriptor ID

15 March 2018

Commons category

Trimipramine

0 references

Identifiers

InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3

1 reference

language of work or name

trimipramine (English)

3 October 2016

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

2 references

language of work or name

trimipramine (English)

3 October 2016

ChEBI release 2020-09-01

CAS Registry Number

1 reference

language of work or name

trimipramine (English)

3 October 2016

1 reference

language of work or name

Trimipramine (English)

3 October 2016

2 references

language of work or name

trimipramine (English)

3 October 2016

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

Reaxys registry number

1321466

1 reference

language of work or name

trimipramine (English)

3 October 2016

mapping relation type

2 references

language of work or name

trimipramine (English)

3 October 2016

matched by identifier from

International Chemical Identifier

InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3

1 reference

language of work or name

TRIMIPRAMINE (English)

3 October 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

UniChem compound ID

1 reference

MassBank accession ID

MSBNK-Eawag-EA286101

0 references

MSBNK-Eawag-EA286102

0 references

MSBNK-Eawag-EA286103

0 references

MSBNK-Eawag-EA286104

0 references

MSBNK-Eawag-EA286105

0 references

MSBNK-Eawag-EA286106

0 references

MSBNK-Eawag-EA286107

0 references

MSBNK-Eawag-EA286108

0 references

MSBNK-Eawag-EA286109

0 references

MSBNK-Eawag-EA286110

0 references

MSBNK-Eawag-EA286111

0 references

MSBNK-Eawag-EA286112

0 references

MSBNK-Eawag-EA286113

0 references

MSBNK-Eawag-EA286114

0 references

MSBNK-Waters-WA000608

0 references

MSBNK-Waters-WA000609

0 references

MSBNK-Waters-WA000610

0 references

MSBNK-Waters-WA000611

0 references

MSBNK-Waters-WA000612

0 references

MSBNK-Waters-WA000613

0 references

splash10-0002-0090000000-683044c8af33df070967

0 references

splash10-0udj-1960000000-2c69c2591b0ff915ccc2

0 references

splash10-0zfr-3920000000-7c68e89e7f53026fdb80

0 references

splash10-0zfr-4930000000-f1fe2a4f61bfbec6d778

0 references

splash10-0pb9-7920000000-b085a14dd7e5d88d4922

0 references

splash10-0a4l-9810000000-b67a0e6866c4bcb27488

0 references

splash10-0002-0090000000-90da643ba602b4854ad4

0 references

splash10-0udj-1960000000-953dd8f5d50ce412ae55

0 references

splash10-0zfr-2920000000-493d39be6384cb3b09d4

0 references

splash10-0zfr-4920000000-02c877be6bc360fbe70e

0 references

splash10-0pb9-6920000000-eb3878e47d12e4792744

0 references

splash10-0a4l-8910000000-5341bd1feea3e6a75bc8

0 references

splash10-0udi-0900000000-875e7a40df38e129227c

0 references

splash10-0a4m-5790000000-53c724efbeeb45818f39

0 references

NMRShiftDB structure ID

1 reference

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

DSSTox substance ID

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

DSSTOX compound identifier

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Trimipramine (English)

CAS no.: 739-71-9 (English)

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Trimipramine (English)

CAS no.: 739-71-9 (English)

1 reference

language of work or name

Trimipramine (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

trimipramine (English)

3 October 2016

MeSH descriptor ID

subject named as

Trimipramine

0 references

D03.633.300.240.918

0 references

1 reference

26 February 2018

1 reference

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

Human Metabolome Database ID

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

2 references

language of work or name

Trimipramine (English)

3 October 2016

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

1 reference

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

1 reference

matched by identifier from

ZSCDBOWYZJWBIY-UHFFFAOYSA-N

MedlinePlus drug identifier

0 references

PatientsLikeMe treatment ID

0 references

1 reference

language of work or name

TRIMIPRAMINE (English)

19 January 2016

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

trimipramine (English)

3 October 2016

1 reference

6 April 2020

0 references

1 reference

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

0 references

WikiProjectMed ID

0 references

WordNet 3.1 Synset ID

04490655-n

1 reference

Sitelinks

Wikipedia(21 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswiki Category:Trimipramine

Retrieved from "https://www.wikidata.org/w/index.php?title=Q423498&oldid=2263293283"